Vivimed Labs receives approval for 3 products from its Hyderabad site
Vivimed Labs announced today that it received approvals for 3
products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site.
1. Bilastine tablets 20mg under brand name FLUSTIN
2. Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI
3. Paracetamol 12Smg/Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name
FEBRIL
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 16 2021 | 2:40 PM IST